AnaptysBio, Inc. (ANAB)
57.93
+0.16
(+0.28%)
USD |
NASDAQ |
May 27, 14:03
AnaptysBio Free Cash Flow : 4.409M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -127.30M |
| TG Therapeutics, Inc. | -14.19M |
| ADMA Biologics, Inc. | 107.55M |
| Mirum Pharmaceuticals, Inc. | -182.55M |
| Rocket Pharmaceuticals, Inc. | -179.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.92M |
| Cash from Investing (Quarterly) | 34.98M |
| Cash from Financing (Quarterly) | 1.209M |
| Free Cash Flow Per Share (Quarterly) | -0.904 |
| Free Cash Flow to Equity (Quarterly) | -12.65M |
| Free Cash Flow to Firm (Quarterly) | -5.061M |
| Free Cash Flow Yield | 0.26% |